Skip to Content

Congresswoman Diana DeGette advocates for affordable health coverage at HCA HealthONE Rose

Congresswoman Diana DeGette joined healthcare experts including HCA HealthONE Rose CEO, Casey Guber for a press conference to discuss the impact of the Enhanced Premium Tax Credits (EPTC) program. This initiative helps 24 million Americans afford health insurance, and will expire in December 2025 without congressional action.

August 11, 2025
Congresswoman Diana DeGette stands at speaks from podium sided by HCA Healthcare staff and physicians.

HCA HealthONE Rose welcomed Congresswoman Diana DeGette for a press conference focused on the future of the Enhanced Premium Tax Credits (EPTC) program, a critical initiative that currently helps 24 million Americans afford health insurance. Without congressional action, the program is set to expire in December 2025.

During her remarks, Congresswoman DeGette emphasized the urgent need to preserve the EPTC program, citing its role in expanding coverage since 2021. “In [Colorado], we’re going to see average premium increases over 38% for the next year, which is shocking. That’s not just for people who are on Medicaid — that’s the insurance rates for all of Colorado. Driving these increases is the loss of additional financial assistance that helps middle-class Coloradoans afford health insurance.”

Casey Guber, President & CEO of HCA HealthONE Rose, spoke about the challenges that healthcare providers face and the potential consequences for patients. “If these tax credits expire, hundreds of thousands of Coloradans will see their premiums dramatically increase. Additionally, many may lose coverage because they can’t afford it anymore,” Guber said. “Our goal is for our community to have access to their health needs — preventative services, specialty care, hospital care — without overburdening our emergency departments.” He highlighted the financial impact on working families, noting that a family of four earning just over six figures could see their premiums increase by as much as $7,800 annually.

To offer a different perspective, Adam Fox of Colorado Consumer Health Initiative spoke on how the expiration of EPTCs will destabilize the health insurance market. “It deals a major blow to the stability of the insurance risk pool, and that is what is driving these base rate increases.” The event also featured speakers from the Colorado Hospital Association, Connect for Health Colorado, and Doctors Care.

HCA HealthONE Rose remains committed to advocating for policies that ensure access to affordable healthcare for all Coloradans.

Learn more and help extend the EPTC program.

Published:
August 11, 2025
Location:
HCA HealthONE Rose

Related Newsroom Articles

Retatrutide is a new GLP-1 hit. But is it legal?
November 14, 2025
You've heard of the popular (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound), but there's a new kid on the block.
Retatrutide is a new GLP-1 hit. But is it legal?
November 14, 2025
You've heard of the popular (GLP-1) receptor agonist drug semaglutide (Ozempic, Wegovy) and GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound), but there's a new kid on the block.
Pyrocarbon built to last in young patients with OA
November 11, 2025
Historically, glenohumeral OA in young patients was treated with TSA or hemiarthroplasty with metallic heads.
Menopause will happen to every woman...how to advocate for yourself
November 05, 2025
Despite how common it is, research funding to study menopause has been limited.